Panbio and Corixa link up on tick borne diseases tests
This article was originally published in Clinica
Australian diagnostics firm Panbio has bought intellectual property from Corixa to develop assays for diagnosing the tick borne diseases, ehrlichiosis and babesiosis.
You may also be interested in...
Following hot on the heels of its Rapidly Manufactured Ventilator Specification document, the UK’s regulator has issued another speedy regulatory permit for fast production of respiratory assist devices.
Which drug candidates represent hope, and which hype? The Scrip team examine the COVID-19 pipeline, lessons from China, and some long term impacts on the sector.
China insists there is no double standard and won’t tolerate any quality issues in its centralized procurement process.